Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells
J. Clin. Invest. Michael G. Kharas, et al. 118:3038
doi:10.1172/JCI33337 [Go to this article.]

Problems with a PDF?